Bellone RR - Search Results

1

Bellone RR, Avila F. Bellone RR, et al. Vet Clin North Am Equine Pract. 2020 Aug;36(2):211-234. doi: 10.1016/j.cveq.2020.03.003. Epub 2020 Jun 10. Vet Clin North Am Equine Pract. 2020. PMID: 32534857 Review.

2

Limbal squamous cell carcinoma in Haflinger horses.

Lassaline M, Cranford TL, Latimer CA, Bellone RR. Lassaline M, et al. Among authors: bellone rr. Vet Ophthalmol. 2015 Sep;18(5):404-8. doi: 10.1111/vop.12229. Epub 2014 Oct 14. Vet Ophthalmol. 2015. PMID: 25312447

3

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses.

Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C, Malvick J, Wallner B, Brem G, Penedo MC, Lassaline M. Bellone RR, et al. Int J Cancer. 2017 Jul 15;141(2):342-353. doi: 10.1002/ijc.30744. Epub 2017 May 8. Int J Cancer. 2017. PMID: 28425625 Free article.

4

Identification of long non-coding RNA in the horse transcriptome.

Scott EY, Mansour T, Bellone RR, Brown CT, Mienaltowski MJ, Penedo MC, Ross PJ, Valberg SJ, Murray JD, Finno CJ. Scott EY, et al. Among authors: bellone rr. BMC Genomics. 2017 Jul 4;18(1):511. doi: 10.1186/s12864-017-3884-2. BMC Genomics. 2017. PMID: 28676104 Free PMC article.

5

Genetic Testing as a Tool to Identify Horses with or at Risk for Ocular Disorders.

Bellone RR. Bellone RR. Vet Clin North Am Equine Pract. 2017 Dec;33(3):627-645. doi: 10.1016/j.cveq.2017.08.005. Vet Clin North Am Equine Pract. 2017. PMID: 29103563 Review.

6

Genetic risk for squamous cell carcinoma of the nictitating membrane parallels that of the limbus in Haflinger horses.

Singer-Berk M, Knickelbein KE, Vig S, Liu J, Bentley E, Nunnery C, Reilly C, Dwyer A, Drögemüller C, Unger L, Gerber V, Lassaline M, Bellone RR. Singer-Berk M, et al. Among authors: bellone rr. Anim Genet. 2018 Oct;49(5):457-460. doi: 10.1111/age.12695. Epub 2018 Jul 12. Anim Genet. 2018. PMID: 29999543

7

Limbal squamous cell carcinoma in a Rocky Mountain Horse: Case report and investigation of genetic contribution.

Knickelbein KE, Lassaline ME, Bellone RR. Knickelbein KE, et al. Among authors: bellone rr. Vet Ophthalmol. 2019 Mar;22(2):201-205. doi: 10.1111/vop.12612. Epub 2018 Sep 20. Vet Ophthalmol. 2019. PMID: 30238589

8

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses.

Knickelbein KE, Lassaline ME, Singer-Berk M, Reilly CM, Clode AB, Famula TR, Michau TM, Bellone RR. Knickelbein KE, et al. Among authors: bellone rr. Equine Vet J. 2020 Jan;52(1):34-40. doi: 10.1111/evj.13116. Epub 2019 Apr 15. Equine Vet J. 2020. PMID: 30903710

9

Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Saldinger LK, et al. Among authors: bellone rr. Vet Ophthalmol. 2020 Jan;23(1):160-170. doi: 10.1111/vop.12704. Epub 2019 Aug 22. Vet Ophthalmol. 2020. PMID: 31441218 Free PMC article.

10

Warmblood fragile foal syndrome type 1 mutation (PLOD1 c.2032G>A) is not associated with catastrophic breakdown and has a low allele frequency in the Thoroughbred breed.

Bellone RR, Ocampo NR, Hughes SS, Le V, Arthur R, Finno CJ, Penedo MCT. Bellone RR, et al. Equine Vet J. 2020 May;52(3):411-414. doi: 10.1111/evj.13182. Epub 2019 Oct 4. Equine Vet J. 2020. PMID: 31502696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page